Even more, the expression and prognostic value of FoxM1 in BC patients were highly associated with molecular subtypes and expressions of ER/PR, which imply the potentiality of FoxM1 acting as a master gene with important functions in breast cancer. This evidence concerns the gene FOXM1 and breast carcinoma.